- ALEX P. NGUYEN ONCOLOGY CONSULTANTS PA UPDATE
- ALEX P. NGUYEN ONCOLOGY CONSULTANTS PA TRIAL
- ALEX P. NGUYEN ONCOLOGY CONSULTANTS PA SERIES
Peguero JA, Kemp B, Camacho LH and Campos LT, Role of chemokines in tumor to tumor metastasis. Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW13, Sabo JR13, Litton JK12. Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK.
ALEX P. NGUYEN ONCOLOGY CONSULTANTS PA UPDATE
Liquid biopsy in advanced gastric malignancy and molecular targeted therapy A case report and update pertaining anti Her2-Neu therapy. Autoimmune hemolytic anemia presenting concurrently with thrombotic thrombocytopenic purpura.
2:57-60,2016.Īl-Kadhimi M, Wah F, Al-Dawoodi T, Peguero J, Campos LT. Syringoid eccrine carcinoma: A case report and literature review of therapeutic options.
ALEX P. NGUYEN ONCOLOGY CONSULTANTS PA TRIAL
Piha-Paul Successful implementation of a novel trial model: The Signature program, ASCO J Clin Oncol 33, 2015Īl-Kadhimi M, Al-Dawoodi T, Peguero J, Campos LT. Knost, Matthew Taylor, Fadi Braiteh, Paul Eder, Howard Safran, Bert O’Neil, Ajjai Alva, Lincoln Nadauld, Prashant Joshi, Rajinder Sidhu, Joy Ero, Eric Slosberg, Claudia Lebedinsky, Barinder Kang, Sudha Parasuraman, Sarina A. Peguero J, Khanfar A, Mannem S, Willis M, Markowtiz A.
ALEX P. NGUYEN ONCOLOGY CONSULTANTS PA SERIES
ASH, December 2014.īarinder K, Slosberg E, Piha Paul S, Braiteh F, Peguero J, Spitz D*, Knost J*, Berry D, Salvado A, Stein S, Lebedinsky C., Metastatic Breast Cancers By FoundationOne® Allows A Broad Genomic Understanding For Potential Clinical Implications The Signature Program, a Series of Tissue-Agnostic, Mutation-Specific Signal-Finding Trials, DecemBlood: 124 (21) The Signature Program, a Distinctive Tissue Agnostic Trial Model for Molecularly Pre-Selected Hematological and Solid Tumor Patients. Giles F, Piha-Paul SA, Spira AI, Braiteh F, Peguero JA, Spitz DL, Knost JA, Schwartzberg L, Stein S, Salvado AJ, Lebedinsky C, Kang B, Slosberg E. Giles F, Piha-Paul SA, Spira AI, Braiteh F, Peguero JA, Spitz DL, Knost JA, Schwartzberg L, Stein S, Salvado AJ, Lebedinsky C, Kang, Slosberg E.
Chemokine expression in tumor-to-tumor metastasis. Peguero JA, Camacho LH, Kemp B, Campos LT. Correspondence: Department of Breast Medical Oncology and Systems Biology, The University Of Texas, M.D. Revista Med Triple Receptor Negative Breast Cancer. Practitioners, click here to view instructions for accessing the list in HCS.Peguero JA, Gonzalez-Angulo AM. The list of registered practitioners within the HCS can be accessed by a patient's treating practitioner. Additional registered practitioners have either not consented to have their information listed or have consented to only being listed within the Department's Health Commerce System (HCS). The list displayed below includes only those practitioners who have consented to be listed on the Department's public website. Please note that this list does not include all of the practitioners registered with the Department to certify patients for medical marijuana. Public List of Consenting Medical Marijuana Program Practitioners
0 kommentar(er)
